Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Andy McEnroe has joined the firm...
-
14:45 London, 00:00 Helsinki, 31 March 2025 - Afarak Group SE ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR) CHANGES REGARDING AFARAK GROUP SE’S TREASURY SHARES Stock Exchange Release ...
-
CHICAGO, March 31, 2025 (GLOBE NEWSWIRE) -- Hydefy is redefining what’s possible with fungi-based materials, now offering a new option for designers in fashion, automotive, and interior industries....
-
— Leading cloud services providers expand their adoption of EPYC CPUs to meet growing public cloud demand — SANTA CLARA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD)...
-
Toronto, ON, March 31, 2025 (GLOBE NEWSWIRE) -- TORONTO, ON, March 31, 2025 (GLOBE NEWSWIRE) — MS Canada invites Canadians across the country to join the MS community at one of the 11 MS Bike events...
-
TransPerfect’s GlobalLink Named Leader in Enterprise Translation Management in G2 Spring 2025 Report
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- TransPerfect, the world’s largest provider of language and AI solutions for global business, today announced that its GlobalLink® platform has been...
-
SOLANA BEACH, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...
-
LONDON, March 31, 2025 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (referred to herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of...
-
Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for more than 2½ yearsFDA requires drug to show long-term...
-
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is...